Changes in muscle mass and strength after menopause

Journal of Musculoskeletal Neuronal Interactions

Volumn 9, Issue 4, 2009, Pages 186-197

  Maltais, M L ^a   Desroches, J ^a   Dionne, Isabelle J ^a  

^a NONE

Author keywords

Exercise; Nutritional supplements; Postmenopausal women; Sarcopenia

Indexed keywords

ESTROGEN; GROWTH HORMONE; ISOFLAVONE; PRASTERONE; VITAMIN D;

BONE DENSITY; DAILY LIFE ACTIVITY; DEVELOPED COUNTRY; DIET SUPPLEMENTATION; ELDERLY CARE; ESTROGEN DEFICIENCY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MENOPAUSAL SYNDROME; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE EXERCISE; MUSCLE FORCE; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE TRAINING; MUSCLE WEAKNESS; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; POSTMENOPAUSE; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; VITAMIN D DEFICIENCY;

EXERCISE; FEMALE; HUMANS; MUSCLE STRENGTH; MUSCLE, SKELETAL; ORGAN SIZE; POSTMENOPAUSE;

EID: 73649095087     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Population division, department of economic and social affairs, united nations secretariat The Ageing of the World's Population 2007, (cited 2009 Mai 14). Available from: http://www.un.org/ageing/popageing.html.
2. Lindsay R. Osteoporosis 1992, Chicago (IL): National Osteoporosis Foundation.
3. Roubenoff R, Hughes VA. Sarcopenia: current concepts. J Gerontol A Biol Sci Med Sci 2000;55:M716-24.
4. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, Tobin J, et al. Age and gender comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol 1997;83:1581-7.
5. Gallagher D, Visser M, De Meersman RE, Sepulveda D, Baumgartner RN, Pierson RN, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 1997;83:229-39.
6. Calmels P, Vico L, Alexandre C, Minaire P. Cross-sectional study of muscle strength and bone mineral density in a population of 106 women between the ages of 44 and 87 years: relationship with age and menopause. Eur J Appl Physiol Occup Physiol 1995; 70:180-6.
7. Petrofsky JS, Burse RL, Lind AR. Comparison of physiological responses of women and men to isometric exercise. J Appl Physiol 1975;38:863-8.
8. Phillips SK, Rook KM, Siddle NC, Bruce SA, Woledge RC. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin Sci (Lond) 1993;84:95-8.
9. Stanley SN, Taylor NA. Isokinematic muscle mechanics in four groups of women of increasing age. Eur J Appl Physiol Occup Physiol 1993;66:178-84.
10. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med 2001;137: 231-243.
11. Dionne IJ, Kinaman KA, Poehlman ET. Sarcopenia and muscle function during menopause and hormone-replacement therapy. J Nutr Health Aging 2000; 4:156-61.
12. Adams O. Life expectancy in Canada - an overview. Health Rep 1990;2:361-76.
13. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11.
14. Carville SF, Rutherford OM, Newham DJ. Power output, isometric strength and steadiness in the leg muscles of pre- and postmenopausal women; the effects of hormone replacement therapy. Eur J Appl Physiol 2006;96:292-8.
15. Cooper R, Mishra G, Clennell S, Guralnik J, Kuh D. Menopausal status and physical performance in midlife: findings from a British birth cohort study. Menopause 2008;15:1079-85.
16. Greeves JP, Cable NT, Reilly T, Kingsland C. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci (Lond) 1999;97:79-84.
17. Kurina LM, Gulati M, Everson-Rose SA, Chung PJ, Karavolos K, Cohen NJ, et al. The effect of menopause on grip and pinch strength: results from the Chicago, Illinois, site of the Study of Women's Health Across the Nation. Am J Epidemiol 2004;160: 484-91.
18. Samson MM, Meeuwsen IB, Crowe A, Dessens JA, Duursma SA, Verhaar HJ. Relationships between physical performance measures, age, height and body weight in healthy adults. Age Ageing 2000;29:235-42.
19. Skelton DA, Phillips SK, Bruce SA, Naylor CH, Woledge RC. Hormone replacement therapy increases isometric muscle strength of adductor pollicis in postmenopausal women. Clin Sci (Lond) 1999;96:357-64.
20. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-63.
21. Short KR, Nair KS. The effect of age on protein metabolism. Curr Opin Clin Nutr Metab Care 2000;3:39-44.
22. Aloia JF, McGowan DM, Vaswani AN, Ross P, Cohn S. H. Relationship of menopause to skeletal and muscle mass. Am J Clin Nutr 1991;53:1378-83.
23. Rolland YM, Perry HM III, Patrick P, Banks WA, Morley JE. Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci 2007;62:330-5.
24. Tanko LB, Movsesyan L, Mouritzen U, Christiansen C. and Svendsen, O. L. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism 2002;51:69-74.
25. Hansen RD and Allen BJ. Habitual physical activity, anabolic hormones, and potassium content of fat-free mass in postmenopausal women. Am J Clin Nutr 2002;75:314-20.
26. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006;119(6):526.e9-17.
27. Kenny AM, Dawson L, Kleppinger A, Iannuzzi-Sucich M, Judge JO. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. J Gerontol A Biol Sci Med Sci 2003;58:M436-40.
28. Jubrias SA, Odderson IR, Esselman PC, Conley KE. Decline in isokinetic force with age: muscle cross-sectional area and specific force. Pflugers Arch 1997;434:246-53.
29. Forsberg AM, Nilsson E, Werneman J, Bergstrom J, Hultman E. Muscle composition in relation to age and sex. Clin Sci (Lond) 1991;81:249-56.
30. Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ 2008;32:120-6.
31. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 2002;80:753-69.
32. Hamilton MT, Areiqat E, Hamilton DG, Bey L. Plasma triglyceride metabolism in humans and rats during aging and physical inactivity. Int J Sport Nutr Exerc Metab 2001;11Suppl:S97-104.
33. van den Brule F, Gaspard U. Body mass changes at menopause: impact of therapeutic strategies. Rev Med Liege 2003;58:734-40.
34. Rebuffe-Scrive M, Eldh J, Hafstrom LO, Bjorntorp P. Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism 1986;35:792-7.
35. Rebuffe-Scrive M, Lonnroth P, Marin P, Wesslau C, Bjorntorp P, Smith U. Regional adipose tissue metabolism in men and postmenopausal women. Int J Obes 1987;11:347-55.
36. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-70.
37. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000;49:467-72.
38. Signorelli SS, Neri S, Sciacchitano S, Pino LD, Costa MP, Marchese G, et al. Behaviour of some indicators of oxidative stress in postmenopausal and fertile women. Maturitas 2006;53:77-82.
39. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 1999;107:123-36.
40. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002;57: M772-7.
41. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008;29:407-14.
42. Louard RJ, Fryburg DA, Gelfand RA, Barrett EJ. Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. J Clin Invest 1992;90:2348-54.
43. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 2002;76:473-81.
44. Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 1990;140:41-54.
45. Pollock ML, Graves JE, Swart DL, Lowenthal DT. Exercise training and prescription for the elderly. South Med J 1994;87:S88-95.
46. Bouchard DR, Soucy L, Senechal M, Dionne IJ, Brochu M. Impact of resistance training with or without caloric restriction on physical capacity in obese older women. Menopause 2009;16:66-72.
47. Asikainen TM, Kukkonen-Harjula K, Miilunpalo S. Exercise for health for early postmenopausal women: a systematic review of randomised controlled trials. Sports Med 2004;34:753-78.
48. th edition ed. 1989, Washington, DC: National Academy Press.
49. Wolfe RR, Miller SL, Miller KB. Optimal protein intake in the elderly. Clin Nutr 2008;27:675-84.
50. Bopp MJ, Houston DK, Lenchik L, Easter L, Kritchevsky SB, Nicklas BJ. Lean mass loss is associated with low protein intake during dietary-induced weight loss in postmenopausal women. J Am Diet Assoc 2008;108:1216-20.
51. Lord C, Chaput JP, Aubertin-Leheudre M, Labonte M, Dionne IJ. Dietary animal protein intake: association with muscle mass index in older women. J Nutr Health Aging 2007;11:383-7.
52. Kyle UG, Genton L, Hans D, Karsegard L, Slosman DO, Pichard C. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. European Journal of Clinical Nutrition 2001;55:663-72.
53. Pansini F, Cervellati C, Guariento A, Stacchini MA, Castaldini C, Bernardi A, et al. Oxidative stress, body fat composition, and endocrine status in pre- and postmenopausal women. Menopause 2008;15:112-8.
54. Hiona A, Leeuwenburgh C. The role of mitochondrial DNA mutations in aging and sarcopenia: implications for the mitochondrial vicious cycle theory of aging. Exp Gerontol 2008;43:24-33.
55. Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic Biol Med 1990;8:523-39.
56. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57:M326-32.
57. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med 1991;151:97-102.
58. Mittal PC, Kant R. Correlation of increased oxidative stress to body weight in disease-free post menopausal women. Clin Biochem 2009;42:1007-11.
59. Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res 2006;40:1359-65.
60. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl.):1689S-96S.
61. Holick MF. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications., in: F. MJ, Editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott Williams & Wilkins; 1999, p. 92-98.
62. Zanello SB, Collins ED, Marinissen MJ, Norman AW, Boland RL. Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm Metab Res 1997;29:231-6.
63. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB, et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001;33:19-24.
64. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004;80:752-8.
65. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-72.
66. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006;91:2980-5.
67. Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinol Jpn 1979;26(Suppl.):65-72.
68. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113-8.
69. Labrie F, Luu-The V, Belanger A, Lin SX, Simard J, Pelletier G, et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169-96.
70. Yen SS, Morales AJ, Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci 1995;774:128-42.
71. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551-5.
72. Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev 2004;25:693-721.
73. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and pre-menopausal women. J Clin Endocrinol Metab 1996;81:2460-7.
74. Kalleinen N, Polo-Kantola P, Irjala K, Porkka-Heiskanen T, Vahlberg T, Virkki A, et al. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment. J Clin Endocrinol Metab 2008;93:1655-61.
75. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-8.
76. Rudman D. Growth hormone, body composition, and aging. J Am Geriatr Soc 1985;33:800-7.
77. Monier S, Le Marchand-Brustel Y. Effects of insulin and IGF-I on RNA synthesis in isolated soleus muscle. Mol Cell Endocrinol 1984;37:109-14.
78. Velloso, C. P. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 2008;154:557-68.
79. Pfeilschifter J, Scheidt-Nave C, Leidig-Bruckner G, Woitge HW, Blum WF, Wuster C, et al. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab, 1996;81:2534-40.
80. Girasole G, Giuliani N, Modena AB, Passeri G, Pedrazzoni M. Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariectomy in vivo and decrease its release in human osteoblastic cells in vitro. Clin Endocrinol (Oxf) 1999;51:801-7.
81. Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004;50:1967-75.
82. Ferrucci L, Penninx BW, Volpato S, Harris TB, Bandeen-Roche K, Balfour J, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002;50:1947-54.
83. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care 2003;6:295-9.
84. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001;103:947-53.
85. Tsujinaka T, Ebisui C, Fujita J, Kishibuchi M, Morimoto T, Ogawa A, et al. Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun 1995;207:168-74.
86. Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 2005;82:355-65.
87. Chevalier S, Gougeon R, Choong N, Lamarche M, Morais JA. Influence of adiposity in the blunted whole-body protein anabolic response to insulin with aging. J Gerontol A Biol Sci Med Sci 2006;61:156-64.
88. Boirie Y, Gachon P, Cordat N, Ritz P, Beaufrere B. Differential insulin sensitivities of glucose, amino acid, and albumin metabolism in elderly men and women. J Clin Endocrinol Metab 2001;86:638-44.
89. Bemben DA, Fetters NL, Bemben MG, Nabavi N, Koh ET. Musculoskeletal responses to high- and low-intensity resistance training in early postmenopausal women. Med Sci Sports Exerc 2000;32:1949-57.
90. Teixeira PJ, Going SB, Houtkooper LB, Metcalfe LL, Blew RM, Flint-Wagner H. G, et al. Resistance training in postmenopausal women with and without hormone therapy. Med Sci Sports Exerc 2003;35:555-62.
91. Vincent KR, Braith RW, Feldman RA, Magyari PM, Cutler RB, Persin SA, et al. Resistance exercise and physical performance in adults aged 60 to 83. J Am Geriatr Soc 2002;50:1100-7.
92. Bassey EJ, Fiatarone MA, O'Neill EF, Kelly M, Evans WJ, Lipsitz LA. Leg extensor power and functional performance in very old men and women. Clin Sci (Lond) 1992;82:321-7.
93. Hyatt RH, Whitelaw MN, Bhat A, Scott S, Maxwell JD. Association of muscle strength with functional status of elderly people. Age Ageing 1990;19:330-6.
94. Rantanen T. Muscle strength, disability and mortality. Scand J Med Sci Sports 2003;13:3-8.
95. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing 1994;23:371-7.
96. Alexander NB, Schultz AB, Ashton-Miller JA, Gross MM, Giordani B. Muscle strength and rising from a chair in older adults. Muscle Nerve Suppl 1997;5:S56-9.
97. Jette AM, Jette DU. Functional and behavioral consequences of sarcopenia. Muscle Nerve Suppl 1997;5:S39-41.
98. Schultz AB, Ashton-Miller JA, Alexander NB. What leads to age and gender differences in balance maintenance and recovery? Muscle Nerve Suppl 1997;5:S60-4.
99. Asmussen E, Heeboll-Nielsen K. Isometric muscle strength of adult men and women. In: E. Asmussen, Fredsted A, Ryge, E, Editor. Communications from the Testing and Observation Insitute of the Danish National Association for Infantile Paralysis. Copenhagen: 1961. p.
100. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.
101. Sitnick M, Foley AM, Brown M, Spangenburg EE. Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass. J Appl Physiol 2006;100:286-93.
102. Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, Delamarche P. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 2003;35:439-43.
103. Wiik A, Ekman M, Johansson O, Jansson E, Esbjornsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem Cell Biol 2009;131:181-9.
104. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, et al. In vivo imaging of transcriptionally active estrogen receptors. Nat Med 2003;9:82-6.
105. Murphy LJ, Ghahary A. Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 1990;11:443-53.
106. Bassey EJ, Mockett SP, Fentem PH. Lack of variation in muscle strength with menstrual status in healthy women aged 45-54 years: data from a national survey. Eur J Appl Physiol Occup Physiol 1996;73:382-6.
107. Greeves JP, Cable NT, Luckas MJ, Reilly T, Biljan MM. Effects of acute changes in oestrogen on muscle function of the first dorsal interosseus muscle in humans. J Physiol 1997;500(Pt.1):265-70.
108. Humphries B, Triplett-McBride T, Newton RU, Marshall, S, Bronks R, McBride J, et al. The relationship between dynamic, isokinetic and isometric strength and bone mineral density in a population of 45 to 65 year old women. J Sci Med Sport 1999;2:364-74.
109. Faulkner JA, Larkin LM, Claflin DR, Brooks SV. Age-related changes in the structure and function of skeletal muscles. Clin Exp Pharmacol Physiol 2007;34:1091-6.
110. Erim Z, Beg MF, Burke DT, de Luca CJ. Effects of aging on motor-unit control properties. J Neurophysiol 1999;82:2081-91.
111. Widrick JJ, Maddalozzo GF, Lewis D, Valentine BA, Garner DP, Stelzer JE, et al. Morphological and functional characteristics of skeletal muscle fibers from hormone-replaced and nonreplaced postmenopausal women. J Gerontol A Biol Sci Med Sci 2003;58:3-10.
112. Overend TJ, Cunningham DA, Kramer JF, Lefcoe MS, Paterson DH. Knee extensor and knee flexor strength: cross-sectional area ratios in young and elderly men. J Gerontol 1992;47:M204-10.
113. Aniansson A, Rundgren A, Sperling L. Evaluation of functional capacity in activities of daily living in 70-year-old men and women. Scand J Rehabil Med 1980;12:145-54.
114. Wohlers LM, Sweeney SM, Ward CW, Lovering RM, Spangenburg EE. Changes in contraction-induced phosphorylation of AMP-activated protein kinase and mitogen-activated protein kinases in skeletal muscle after ovariectomy. J Cell Biochem 2009;107:171-8.
115. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 2002;282:E1139-46.
116. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005;280:35983-91.
117. Moran AL, Warren GL, Lowe DA. Removal of ovarian hormones from mature mice detrimentally affects muscle contractile function and myosin structural distribution. J Appl Physiol 2006;100:548-59.
118. Jorgensen SB, Richter EA, Wojtaszewski JF. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J Physiol 2006;574(Pt.1):17-31.
119. Osler ME, Zierath JR. Adenosine 5′-monophosphate-activated protein kinase regulation of fatty acid oxidation in skeletal muscle. Endocrinology 2008;149:935-41.
120. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992;55:950-4.
121. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
122. Phillips LS, Langer RD. Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis. Fertil Steril 2005;83:558-66.
123. Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, et al. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 2009;170:12-23.
124. Food and Drug Administration, US Department of Health and Human Services. Guidance for Industry. Noncontraceptive Estrogen Drug Products for the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms - Recommended Prescribing Information for Health Care Providers and Patient Labeling. Draft Guidance. Revision 4. 2005 [cited 2009 July 31st]; Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm075090.pdf.
125. Ransley JK, Donnelly JK, Read NW. Food and nutritional supplements: Their Role in Health and Disease, 2001, New York: Springer-Verlag.
126. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ. Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial. Eur J Clin Nutr 2007;61:1442-4.
127. Martel GF, Roth SM, Ivey FM, Lemmer JT, Tracy BL, Hurlbut DE, et al. Age and sex affect human muscle fibre adaptations to heavy-resistance strength training. Exp Physiol 2006;91:457-64.
128. Wiik A, Hellsten Y, Berthelson P, Lundholm L, Fischer H, Jansson E. Activation of estrogen response elements is mediated both via estrogen and muscle contractions in rat skeletal muscle myotubes. Am J Physiol Cell Physiol 2009;296:C215-20.
129. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 1996;150(Suppl.): S43-50.
130. Villareal DT, Holloszy JO. DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab 2006;291:E1003-8.
131. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006;355:1647-59.
132. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, et al. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 2006;91:2986-93.
133. Igwebuike A, Irving BA, Bigelow ML, Short KR, McConnell JP, Nair KS. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab 2008;93:534-8.
134. Lanfranco F, Gianotti L, Giordano R, Pellegrino M, Maccario M, Arvat E. Ageing, growth hormone and physical performance. J Endocrinol Invest 2003;26:861-72.
135. Fanciulli G, Delitala A, Delitala, G. Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone. Hum Reprod Update 2009;15:341-58.
136. Campbell MJ, McComas AJ, Petito F. Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry 1973;36:174-82.
137. Doherty TJ, Vandervoort AA, Taylor AW, Brown WF. Effects of motor unit losses on strength in older men and women. J Appl Physiol 1993;74:868-74.
138. Essen-Gustavsson B, Borges O. Histochemical and metabolic characteristics of human skeletal muscle in relation to age. Acta Physiol Scand 1986;126:107-14.
139. Delbono O, O'Rourke KS, Ettinger WH. Excitation-calcium release uncoupling in aged single human skeletal muscle fibers. J Membr Biol 1995;148:211-22.
140. Howard JE, McGill KC, Dorfman LJ. Age effects on properties of motor unit action potentials: ADEMG analysis. Ann Neurol 1988;24:207-13.
141. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999;20:279-307.
142. Hampson E. Estrogen-related variations in human spatial and articulatory-motor skills. Psychoneuroendocrinology, 1990;15:97-111.
143. Smith S. The effects of oestrogen and progesterone on GABA and glutamate responses at extrahypothalamic sites., in: P.S. Costa E, Editor. Neurosteroids and Brain Function. New York: Thieme Medical; 1991. p. 87-94.
144. Sipila S, Poutamo J. Muscle performance, sex hormones and training in peri-menopausal and post-menopausal women. Scand J Med Sci Sports 2003;13:19-25.
145. Stel VS, Pluijm SM, Deeg DJ, Smit JH, Bouter LM, Lips P. Functional limitations and poor physical performance as independent risk factors for self-reported fractures in older persons. Osteoporos Int 2004;15:742-50.
146. Lips P. Epidemiology and predictors of fractures associated with osteoporosis. Am J Med 1997;103(2A):3S-8S; discussion 8S-11S.
147. Steiger P, Cummings SR, Black DM, Spencer NE, Genant HK. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 1992;7:625-32